Cargando…

Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019

OBJECTIVES: Due to the increase in life expectancy and the aging of the global population, the “Belt and Road” (“B&R”) countries are faced with varying degrees of lung cancer threat. The purpose of this study is to analyze the differences in the burden and trend of lung cancer disability in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Zhenfeng, Ye, Wenjing, Zhang, Li, Jia, Wenchang, Chen, Binghong, Wang, Qizhe, Cheng, Xuelin, Yang, Shijia, Zhang, Zhaoyu, Ding, Yibo, Li, Xiaopan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668146/
https://www.ncbi.nlm.nih.gov/pubmed/38023230
http://dx.doi.org/10.3389/fonc.2023.1247006
_version_ 1785139405968637952
author Zhu, Zhenfeng
Ye, Wenjing
Zhang, Li
Jia, Wenchang
Chen, Binghong
Wang, Qizhe
Cheng, Xuelin
Yang, Shijia
Zhang, Zhaoyu
Ding, Yibo
Li, Xiaopan
author_facet Zhu, Zhenfeng
Ye, Wenjing
Zhang, Li
Jia, Wenchang
Chen, Binghong
Wang, Qizhe
Cheng, Xuelin
Yang, Shijia
Zhang, Zhaoyu
Ding, Yibo
Li, Xiaopan
author_sort Zhu, Zhenfeng
collection PubMed
description OBJECTIVES: Due to the increase in life expectancy and the aging of the global population, the “Belt and Road” (“B&R”) countries are faced with varying degrees of lung cancer threat. The purpose of this study is to analyze the differences in the burden and trend of lung cancer disability in the “B&R” countries from 1990 to 2019 so as to provide an analytical strategic basis to build a healthy “B&R”. METHODS: Data were derived from the Global Burden of Disease 2019 (GBD 2019). Incidence, mortality, prevalence, the years lived with disability (YLDs), and disability-adjusted life years (DALYs) of lung cancer and those attributable to different risk factors were measured from 1990 to 2019. Trends of disease burden were estimated by using the average annual percent change (AAPC), and the 95% uncertainty interval (UI) was reported. RESULTS: China, India, and the Russian Federation were the three countries with the highest burden of lung cancer in 2019. From 1990 to 2019, the AAPC of incidence, prevalence, mortality, and DALYs generally showed a downward trend in Central Asia (except Georgia) and Eastern Europe, while in China, South Asia (except Bangladesh), most countries in North Africa, and the Middle East, the trend was mainly upward. The AAPC of age-standardized incidence was 1.33% (1.15%–1.50%); the AAPC of prevalence, mortality, and DALYs from lung cancer in China increased by 24% (2.10%–2.38%), 0.94% (0.74%–1.14%), and 0.42% (0.25%–0.59%), respectively. A downward trend of the AAPC values of age-standardized YLD rate in men was shown in the vast majority of “B&R” countries, but for women, most countries had an upward trend. For adults aged 75 years or older, the age-standardized YLD rate showed an increasing trend in most of the “B&R” countries. Except for the DALY rate of lung cancer attributable to metabolic risks, a downward trend of the DALY rate attributable to all risk factors, behavioral risks, and environmental/occupational risks was shown in the vast majority of “B&R” countries. CONCLUSION: The burden of lung cancer in “B&R” countries varied significantly between regions, genders, and risk factors. Strengthening health cooperation among the “B&R” countries will help to jointly build a community with a shared future for mankind.
format Online
Article
Text
id pubmed-10668146
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106681462023-01-01 Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019 Zhu, Zhenfeng Ye, Wenjing Zhang, Li Jia, Wenchang Chen, Binghong Wang, Qizhe Cheng, Xuelin Yang, Shijia Zhang, Zhaoyu Ding, Yibo Li, Xiaopan Front Oncol Oncology OBJECTIVES: Due to the increase in life expectancy and the aging of the global population, the “Belt and Road” (“B&R”) countries are faced with varying degrees of lung cancer threat. The purpose of this study is to analyze the differences in the burden and trend of lung cancer disability in the “B&R” countries from 1990 to 2019 so as to provide an analytical strategic basis to build a healthy “B&R”. METHODS: Data were derived from the Global Burden of Disease 2019 (GBD 2019). Incidence, mortality, prevalence, the years lived with disability (YLDs), and disability-adjusted life years (DALYs) of lung cancer and those attributable to different risk factors were measured from 1990 to 2019. Trends of disease burden were estimated by using the average annual percent change (AAPC), and the 95% uncertainty interval (UI) was reported. RESULTS: China, India, and the Russian Federation were the three countries with the highest burden of lung cancer in 2019. From 1990 to 2019, the AAPC of incidence, prevalence, mortality, and DALYs generally showed a downward trend in Central Asia (except Georgia) and Eastern Europe, while in China, South Asia (except Bangladesh), most countries in North Africa, and the Middle East, the trend was mainly upward. The AAPC of age-standardized incidence was 1.33% (1.15%–1.50%); the AAPC of prevalence, mortality, and DALYs from lung cancer in China increased by 24% (2.10%–2.38%), 0.94% (0.74%–1.14%), and 0.42% (0.25%–0.59%), respectively. A downward trend of the AAPC values of age-standardized YLD rate in men was shown in the vast majority of “B&R” countries, but for women, most countries had an upward trend. For adults aged 75 years or older, the age-standardized YLD rate showed an increasing trend in most of the “B&R” countries. Except for the DALY rate of lung cancer attributable to metabolic risks, a downward trend of the DALY rate attributable to all risk factors, behavioral risks, and environmental/occupational risks was shown in the vast majority of “B&R” countries. CONCLUSION: The burden of lung cancer in “B&R” countries varied significantly between regions, genders, and risk factors. Strengthening health cooperation among the “B&R” countries will help to jointly build a community with a shared future for mankind. Frontiers Media S.A. 2023-11-10 /pmc/articles/PMC10668146/ /pubmed/38023230 http://dx.doi.org/10.3389/fonc.2023.1247006 Text en Copyright © 2023 Zhu, Ye, Zhang, Jia, Chen, Wang, Cheng, Yang, Zhang, Ding and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhu, Zhenfeng
Ye, Wenjing
Zhang, Li
Jia, Wenchang
Chen, Binghong
Wang, Qizhe
Cheng, Xuelin
Yang, Shijia
Zhang, Zhaoyu
Ding, Yibo
Li, Xiaopan
Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019
title Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019
title_full Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019
title_fullStr Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019
title_full_unstemmed Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019
title_short Diversities of disability caused by lung cancer in the 66 Belt and Road initiative countries: a secondary analysis from the Global Burden of Disease Study 2019
title_sort diversities of disability caused by lung cancer in the 66 belt and road initiative countries: a secondary analysis from the global burden of disease study 2019
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668146/
https://www.ncbi.nlm.nih.gov/pubmed/38023230
http://dx.doi.org/10.3389/fonc.2023.1247006
work_keys_str_mv AT zhuzhenfeng diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT yewenjing diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT zhangli diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT jiawenchang diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT chenbinghong diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT wangqizhe diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT chengxuelin diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT yangshijia diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT zhangzhaoyu diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT dingyibo diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019
AT lixiaopan diversitiesofdisabilitycausedbylungcancerinthe66beltandroadinitiativecountriesasecondaryanalysisfromtheglobalburdenofdiseasestudy2019